Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.

Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.

Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

Yan Zhao talks about how her team in China responded to an emerging public health crisis.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Researchers race to put hydroxychloroquine to the test in a large study.